Is Zantac recalled?

OTC medicine · checked against 8 official databases (US · Canada · UK) · newest matching record: January 15, 2020

FDA food enforcement US

No matching records.

FDA drug enforcement US

• Ranitidine 300 mg, 30 Tabs bottles, Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 NDC 61919-455-30Class II
  Jan 15, 2020 · Direct Rx · #D-0017-2021
  CGMP Deviations: Presence of NDMA impurity detected in product.
  View official record →
• Ranitidine 150 mg, a) 60 Tabs (NDC 61919-339-60); and b) 90 Tabs (NDC 61919-339-90) bottles, Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30…Class II
  Jan 15, 2020 · Direct Rx · #D-0016-2021
  CGMP Deviations: Presence of NDMA impurity detected in product.
  View official record →
• Ranitidine Hydrochloride (powder), USP, Rx only, Spectrum Chemical Mfg Corp., a) 1 gram, b) 5 grams, c) 25 grams, d)100 grams, e) 500 grams, f) 1 KilogramClass II
  Jan 14, 2020 · Spectrum Laboratory Products · #D-0825-2020
  CGMP Deviations: Presence of NDMA impurity detected in product.
  View official record →
• ranitidine hydrochloride, USP ,150 mg tablets a) 14-count bottles ( NDC 43063-844-14); b) 30-count bottles (NDC 43063-844-30); c) 60 -count bottles( NDC 4306…Class II
  Jan 10, 2020 · PD-Rx Pharmaceuticals, Inc. · #D-0826-2020
  CGMP Deviations: Received notice from supplier of potential -Nitrosodimethylamine (NDMA) amounts above established levels.
  View official record →
• Ranitidine Capsules 300 mg, 30 count bottles. Rx only, Manufactured by: Appco Pharma LLC, Piscataway, NJ 08854, Distributed by: ANI Pharmaceuticals, Inc., Baud…Class II
  Jan 7, 2020 · Appco Pharma LLC · #D-0648-2020
  CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API
  View official record →
• Preferred Pharmaceuticals, Inc, Ranitidine Tablets, 300 mg, Rx Only, a) 14 count bottles (NDC: 68788-6382-1), b) 30 count bottles (NDC: 68788-6382-3), c) 90 co…Class II
  Jan 7, 2020 · Preferred Pharmaceuticals, Inc · #D-0797-2020
  CGMP Deviations: Presence of NDMA impurity detected in product.
  View official record →
• Preferred Pharmaceuticals, Inc, Ranitidine Tablets, 150 mg, a) 30 count bottles (NDC: 68788-7388-3), b) 60 count bottles (NDC: 68788-7388-6), c) 90 count bottl…Class II
  Jan 7, 2020 · Preferred Pharmaceuticals, Inc · #D-0796-2020
  CGMP Deviations: Presence of NDMA impurity detected in product.
  View official record →
• Ranitidine Capsules 150 mg, (a) 60 count bottles (NDC 62559-690-60) , (b) 500 count bottles (NDC 62559-690-05), Rx only, Manufactured by: Appco Pharma LLC, Pis…Class II
  Jan 7, 2020 · Appco Pharma LLC · #D-0649-2020
  CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API
  View official record →
• Ranitidine, 150 mg Tablets, a) 7 count, b) 14 count, c) 20 count, d) 30 count, e) 60 count; Rx, Only, H.J. Harkins Company, Inc. dba Pharma Pac Grover Beach, …Class II
  Jan 6, 2020 · H J Harkins Company Inc dba Pharma Pac · #D-0793-2020
  CGMP Deviations: Presence of NDMA impurity detected in product.
  View official record →
• Ranitidine 150 mg tablets, 24 count bottles, NDC 37808-196-01.Class II
  Dec 26, 2019 · AAA Pharmaceutical, Inc. · #D-0645-2020
  CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API
  View official record →

FDA device enforcement US

No matching records.

CPSC consumer products US

No matching records.

Health Canada / CFIA / Transport Canada CA

• Sanofi Consumer Health Zantac Product Recall (2019-10-18)
  date at source · Drugs and health products · #59972
  Product safety
  View official record →
• Acid Reducer (Ranitidine) Tablet: N-nitrosodimethylamine (NDMA) impurity
  date at source · Drugs and health products · #63679
  Contamination
  View official record →
• PMS-Ranitidine 150mg(2021-02-04)
  date at source · Drugs and health products · #62069
  Product safety
  View official record →
• pms-Ranitidine 150mg (2020-08-28)
  date at source · Drugs and health products · #61587
  Product safety
  View official record →
• Ranitidine Injection USP (2020-08-27)
  date at source · Drugs and health products · #61571
  Product safety
  View official record →
• Status of ranitidine drugs in Canada
  date at source · Communications and Public Affairs Branch · #61485
  View official record →
• Laboratoire Riva Inc. Ranitidine Product Recall (2019-10-24)
  date at source · Drugs and health products · #60068
  Product safety
  View official record →
• Sivem Pharmaceuticals ULC Ranitidine Product Recall (2019-10-17)
  date at source · Drugs and health products · #60066
  Product safety
  View official record →
• Sun Pharma Canada Inc. Ranitidine Product Recall (2019-10-29)
  date at source · Drugs and health products · #60064
  Product safety
  View official record →
• Vita Health Products Inc Ranitidine Product Recall (2019-10-24)
  date at source · Drugs and health products · #60057
  Product safety
  View official record →

UK OPSS product safety UK

No matching records.

UK Food Standards Agency UK

No matching records.

USDA FSIS meat & poultry US

No matching records.

Related federal court cases via CourtListener

2695 product-liability or consumer-fraud dockets in federal court name Zantac or a related entity — some are class actions, others individual suits. Newest first.

• TATMAN v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.365 P.I.: Personal Inj. Prod. Liability
  Filed 2026-06-01 · open · E.D. Pa. · No. 2:26-cv-03754
  View docket →
• LASH v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.365 P.I.: Personal Inj. Prod. Liability
  Filed 2026-06-01 · open · E.D. Pa. · No. 2:26-cv-03750
  View docket →
• Perez v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.365 P.I.: Personal Inj. Prod. Liability
  Filed 2026-05-30 · open · E.D. Pa. · No. 2:26-cv-03713
  View docket →
• MYRICK v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.365 P.I.: Personal Inj. Prod. Liability
  Filed 2026-05-15 · open · E.D. Pa. · No. 2:26-cv-03323
  View docket →
• KRAWCIW v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.365 P.I.: Personal Inj. Prod. Liability
  Filed 2026-05-08 · open · E.D. Pa. · No. 2:26-cv-03120
  View docket →
• THOMPSON v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC365 P.I.: Personal Inj. Prod. Liability
  Filed 2026-05-07 · open · E.D. Pa. · No. 2:26-cv-03088
  View docket →

Court filings are allegations, not findings of fault or safety determinations. Cases are matched by party name and may involve unrelated products. This is public-record information, not legal advice.